about
BST2/Tetherin enhances entry of human cytomegalovirusBioactive Molecules Released From Cells Infected with the Human CytomegalovirusHerpesviruses and intermediate filaments: close encounters with the third typeAntigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human AntibodiesThe antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.HCMV spread and cell tropism are determined by distinct virus populations.Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step processHuman cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner.Herpes virus fusion and entry: a story with many characters.Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibodyHuman cytomegalovirus tropism for mucosal myeloid dendritic cells.Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture.The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes.The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex.The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells.The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cellsCytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.Immune-based therapies for cytomegalovirus infection.Cytomegalovirus: a probable cause of steroid-refractory ulcerative colitis.Tetraspanins in infections by human cytomegalo- and papillomaviruses.Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling.Charge cluster-to-alanine scanning of UL128 for fine tuning of the endothelial cell tropism of human cytomegalovirus.Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration.The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic CellsThe m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV.Host protein Snapin interacts with human cytomegalovirus pUL130 and affects viral DNA replication.HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts.Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection.Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton.Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells.Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain.Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells.
P2860
Q21559401-3AFBE3AE-8D66-4A36-B81A-26B656238186Q26744665-8B16EB31-BB4E-42A5-AEBE-C737CB774987Q26863328-2AEC24D6-A229-427D-A808-CF71E0DC3036Q28550400-7BFBB04A-BB8F-416B-B614-CA4CA6937664Q33609914-3A7BCFA8-1992-4FDA-911D-069E243AEF12Q33798083-A37D77EC-82C9-4BB3-A3A0-45F3B8F5EAC5Q33846984-A9684317-8E72-42CD-BF9D-F277A8663A34Q34230355-3374801C-3BC0-4E9E-8DFE-1F915E889C6FQ34285628-0F8518BF-6DFC-4D86-A40A-250BC23AEFA8Q34317887-62F5C4D2-10F5-4B25-9FE4-494E1DA9650CQ34422068-AAA9149A-55B8-4824-B8C2-BED7325A8751Q34468958-AAE40389-776B-491B-9522-7D28E04A2D59Q34642568-A57EFAC4-6940-44F3-A92B-43C13B39FF0FQ34819531-8E135F11-7B79-4545-8116-749261DEDCE2Q34916655-5A91204F-806F-47C7-AB3D-93998D5DD02EQ36086685-7C8D8AE8-448B-4E0F-AD67-C7C99A933FD3Q36827232-BB335AFE-9352-4E9A-AF90-1AA8E8E42F8DQ36973592-AB5B7F60-BF23-4C73-8110-F5942710BED3Q37252891-A2CF5E05-06AE-48F9-93A5-20BFB3CDB096Q37559627-27A157A5-A660-49E4-BFDB-E22EE681D811Q37673149-3A0339A7-9D2D-46C7-ADDA-A9D5D5B14A36Q37773240-6FD3D68C-77F8-4505-B6C2-6598926AF523Q38074485-CFE90947-462E-44AF-BC64-4E16D17E43CEQ38837603-F01F4463-FF21-4F12-A048-ECC87208D8F4Q39673166-0752A67B-8A2B-4D3F-A26F-D3DB9B80636DQ39943786-E16FEC7A-8870-4B17-A7E2-6B70CAEE60F9Q40209543-FC7D6311-5667-4DBC-A600-20A7C1D21384Q40331128-1874DA0B-576E-44FA-9692-D9640CFEFBEFQ40340374-9FE7F68D-DFB2-4493-B43E-9A4F898F8E9FQ40653356-DAFCB9B2-2842-4F24-97E8-2717C3B3316EQ40877837-DB47F413-0D92-4360-8D50-169DB246B91EQ41786247-CC7D87D0-8377-4607-AC46-11B541D78D34Q41881987-9CA9BFDD-B517-4BC7-9360-005C4B4D2EB2Q41909075-68B2904A-E462-4A5F-AA11-20173D65911FQ42220221-0718B080-BDB0-4B25-B976-7458D1641AEEQ42733497-F1592912-5B37-4B45-A9AF-6A6C495E60C1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Entry route of HCMV into endothelial cells.
@en
Entry route of HCMV into endothelial cells.
@nl
type
label
Entry route of HCMV into endothelial cells.
@en
Entry route of HCMV into endothelial cells.
@nl
prefLabel
Entry route of HCMV into endothelial cells.
@en
Entry route of HCMV into endothelial cells.
@nl
P1476
Entry route of HCMV into endothelial cells.
@en
P2093
Christian Sinzger
P304
P356
10.1016/J.JCV.2007.12.002
P577
2008-01-18T00:00:00Z